Andrea On-Yan Luk
Overview
Explore the profile of Andrea On-Yan Luk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ho J, Lau E, O C, Fan B, Ko G, Kong A, et al.
Diabetes Res Clin Pract
. 2024 May;
212:111718.
PMID: 38796080
Background: We compared performance of high 1-hour PG level, impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) in predicting type 2 diabetes in a longitudinal community-based cohort of Hong...
2.
O C, Siu B, Leung V, Lin Y, Ding C, Lau E, et al.
J Diabetes Complications
. 2023 Sep;
37(10):108598.
PMID: 37716256
Aims: To examine the risk association of insomnia with incident chronic cognitive impairment in older adults with type 2 diabetes mellitus (T2D). Methods: Between July 2010 and June 2015, patients...
3.
Kong A, Lau E, O C, Luk A, Yip T, Chow E, et al.
Diabetes Res Clin Pract
. 2023 Jul;
202:110825.
PMID: 37442241
Aims: We aimed to examine the impact of non-alcoholic fatty liver disease (NAFLD) on the clinical outcomes in patients with type 2 diabetes (T2D). Methods: Between 2013 and 2014, 1,734...
4.
Yang A, Wu H, Lau E, Shi M, Fan B, Kong A, et al.
EBioMedicine
. 2022 Aug;
83:104219.
PMID: 35970023
Background: Cancer is replacing cardiovascular-disease as a leading cause of death in type 2 diabetes (T2D). The association of RAS-inhibitors (RASi) and cancer, including differences between angiotensin-converting-enzyme-inhibitor (ACEi) and angiotensin-receptor-blocker...
5.
Cheung E, Kong A, Lau E, Chow E, Luk A, Ma R, et al.
J Diabetes Investig
. 2021 Feb;
12(9):1739-1748.
PMID: 33605046
Introduction: Diabetes and bone health are closely related. We examined the incidence and risk factors of hip fractures in Chinese patients with type 2 diabetes (T2D). Materials And Methods: In...
6.
Lee H, Wong G, Kwok R, Choi K, Chan C, Shu S, et al.
Hepatology
. 2020 Jan;
72(4):1230-1241.
PMID: 31991487
Background And Aims: Type 2 diabetes is an important risk factor for nonalcoholic fatty liver disease (NAFLD) and advanced fibrosis. Current international guidelines recommend the use of noninvasive tests as...
7.
Yeung M, Wong G, Choi K, Luk A, Kwok R, Shu S, et al.
J Hepatol
. 2017 Oct;
PMID: 28989092
Background & Aims: Increasing evidence suggests that non-alcoholic fatty liver disease (NAFLD) may be an independent risk factor for chronic kidney disease (CKD). Given the high prevalence of NAFLD among...
8.
Cheung K, Lau E, So W, Ma R, Ozaki R, Kong A, et al.
Diabetes Res Clin Pract
. 2016 Dec;
123:97-105.
PMID: 27997863
Aims: To assess the implications of low testosterone on cardiovascular risk factors, metabolic syndrome (MES) and clinical outcomes in Chinese men with Type 2 Diabetes (T2D). Methods: A prospective cohort...
9.
Kwok R, Choi K, Wong G, Zhang Y, Chan H, Luk A, et al.
Gut
. 2015 Apr;
65(8):1359-68.
PMID: 25873639
Objective: Type 2 diabetes is an important risk factor for non-alcoholic fatty liver disease (NAFLD), but current guidelines provide conflicting recommendations on whether diabetic patients should be screened for NAFLD....
10.
Wong S, Kong A, Luk A, Ozaki R, Ng V, Lebovitz H, et al.
Diabetes Technol Ther
. 2015 Feb;
17(4):283-90.
PMID: 25710812
Background: Gastrointestinal electromodulation therapy is a novel alternative for achieving diabetes control without traditional bariatric surgery. We compared the efficacy of a meal-initiated implantable gastric contractility modulation (GCM) device with...